NovoCure Ltd — Director's Dealing 2020

May 7, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2020-05-05

Reporting Person: DOYLE WILLIAM F (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-05	Ordinary Shares	M	58768	$61.40	Acquired	628047	Direct
2020-05-05	Ordinary Shares	S	30283	$62.468	Disposed	597764	Direct
2020-05-06	Ordinary Shares	S	29881	$64.27	Disposed	567883	Direct
2020-05-06	Ordinary Shares	M	58768	$64.15	Acquired	626651	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-05	Restricted Stock Units	$0.0	M	58768	Disposed		Ordinary Shares (58768.0)	Direct
2020-05-06	Restricted Stock Units	$0.0	M	58768	Disposed		Ordinary Shares (58768.0)	Direct

Footnotes

F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2: Fully vested as of the date hereof.